Browsing: approved

The Food and Drug Administration (FDA) has approved mFlusiva®, the first mRNA-based influenza vaccine, for adults aged 50 years and older. For persons aged 65 years and older, the vaccine received accelerated approval based on immune responses; continued approval in this age group is contingent upon verification and description of clinical benefit in a confirmatory…

The Wegovy pill contains semaglutide 25 mg and is taken once daily. The approval is based on the OASIS programme, including the OASIS 4 study in 307 adults with obesity or overweight and at least one weight-related comorbidity. The study demonstrated a mean weight loss of 17 per cent compared with 3 per cent for…